These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21491811)

  • 1. Vacuolization of tubules in gadolinium-associated acute renal failure.
    Riviello ED; Wang KC; Hochman ME; Sariban A; Da Rocha RC; Dogaru G; Christopher K
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(1):108-15. PubMed ID: 21491811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of gadolinium contrast angiography in patients with chronic renal insufficiency.
    Sam AD; Morasch MD; Collins J; Song G; Chen R; Pereles FS
    J Vasc Surg; 2003 Aug; 38(2):313-8. PubMed ID: 12891113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal safety of gadolinium-based contrast media in patients with chronic renal insufficiency.
    Ledneva E; Karie S; Launay-Vacher V; Janus N; Deray G
    Radiology; 2009 Mar; 250(3):618-28. PubMed ID: 19244037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadolinium-induced nephrotoxicity.
    Buhaescu I; Izzedine H
    Int J Clin Pract; 2008 Jul; 62(7):1113-8. PubMed ID: 18218006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of gadolinium for arterial interventions.
    Sambol EB; Van der Meer JG; Graham A; Goldstein LJ; Karwowski JK; Dayal R; Derubertis B; Kent KC
    Ann Vasc Surg; 2011 Apr; 25(3):366-76. PubMed ID: 21288688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadolinium-based percutaneous coronary intervention in a patient with renal insufficiency.
    Bokhari SW; Wen YH; Winters RJ
    Catheter Cardiovasc Interv; 2003 Mar; 58(3):358-61. PubMed ID: 12594702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are gadolinium-based contrast media nephrotoxic? A renal biopsy study.
    Akgun H; Gonlusen G; Cartwright J; Suki WN; Truong LD
    Arch Pathol Lab Med; 2006 Sep; 130(9):1354-7. PubMed ID: 16948524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephrotoxicity of gadolinium-based contrast in the setting of renal artery intervention: retrospective analysis with 10-year follow-up.
    Takahashi EA; Kallmes DF; Mara KC; Harmsen WS; Misra S
    Diagn Interv Radiol; 2018 Nov; 24(6):378-384. PubMed ID: 30406762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does gadolinium-based angiography protect against contrast-induced nephropathy?: a systematic review of the literature.
    Boyden TF; Gurm HS
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):687-93. PubMed ID: 18360867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Non-iodinated contrast media nephrotoxicity].
    Janus N; Launay-Vacher V; Deray G
    Nephrol Ther; 2018 Nov; 14(6):484-490. PubMed ID: 30301611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimetazidine in the prevention of contrast-induced nephropathy in chronic kidney disease.
    Ibrahim TA; El-Mawardy RH; El-Serafy AS; El-Fekky EM
    Cardiovasc Revasc Med; 2017; 18(5):315-319. PubMed ID: 28532702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of single-bolus administration of sodium bicarbonate to prevent contrast-induced nephropathy in patients with mild renal insufficiency undergoing an elective coronary procedure.
    Tamura A; Goto Y; Miyamoto K; Naono S; Kawano Y; Kotoku M; Watanabe T; Kadota J
    Am J Cardiol; 2009 Oct; 104(7):921-5. PubMed ID: 19766757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrogenic systemic fibrosis: a gadolinium-associated fibrosing disorder in patients with renal dysfunction.
    Kay J
    Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii66-9. PubMed ID: 19022818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negligible Risk of Acute Renal Failure Among Hospitalized Patients After Contrast-Enhanced Imaging With Iodinated Versus Gadolinium-Based Agents.
    Gorelik Y; Yaseen H; Heyman SN; Khamaisi M
    Invest Radiol; 2019 May; 54(5):312-318. PubMed ID: 30480553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Neutrophil Gelatinase-Associated Lipocalin and Urinary Kidney Injury Molecule-1 as Potential Biomarkers of Subclinical Nephrotoxicity After Gadolinium-Based and Iodinated-Based Contrast Media Exposure in Pediatric Patients with Normal Kidney Function.
    Spasojević-Dimitrijeva B; Kotur-Stevuljević J; Đukić M; Paripović D; Miloševski-Lomić G; Spasojević-Kalimanovska V; Pavićević P; Mitrović J; Kostić M
    Med Sci Monit; 2017 Sep; 23():4299-4305. PubMed ID: 28874655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid deterioration of renal insufficiency after magnetic resonance imaging with gadolinium-based contrast agent.
    Fujisaki K; Ono-Fujisaki A; Kura-Nakamura N; Komune N; Hirakawa N; Tsuruya K; Komune S; Iida M
    Clin Nephrol; 2011 Mar; 75(3):251-4. PubMed ID: 21329636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zeroing on Gadolinium to Complement Intravascular Ultrasound in Zero-Contrast Percutaneous Coronary Interventions.
    Lichaa H
    J Invasive Cardiol; 2022 Jun; 34(6):E477-E480. PubMed ID: 35652711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute renal failure after arteriography with a gadolinium-based contrast agent.
    Gemery J; Idelson B; Reid S; Yucel EK; Pagan-Marin H; Ali S; Casserly L
    AJR Am J Roentgenol; 1998 Nov; 171(5):1277-8. PubMed ID: 9798860
    [No Abstract]   [Full Text] [Related]  

  • 19. Gadolinium-contrast toxicity in patients with kidney disease: nephrotoxicity and nephrogenic systemic fibrosis.
    Perazella MA
    Curr Drug Saf; 2008 Jan; 3(1):67-75. PubMed ID: 18690983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An uninvestigated risk factor for contrast-induced nephropathy in chronic kidney disease: proteinuria.
    Piskinpasa S; Altun B; Akoglu H; Yildirim T; Agbaht K; Yilmaz R; Peynircioglu B; Cil B; Aytemir K; Turgan C
    Ren Fail; 2013; 35(1):62-5. PubMed ID: 23176376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.